A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia

NCT04577352 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Friedreich Ataxia

Interventions

DRUG: Vatiquinone
DRUG: Placebo

Sponsor

PTC Therapeutics